Schedule 13D ownership disclosure
Entrada Therapeutics Inc
Security class unavailable · CUSIP: 29384C108
Event date: 2021-11-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,276,022
- Percent of class
- 11.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-138124
- Form type
- SC 13D
- Filer
- 5AM Ventures V, L.P.
- CIK
- CIK 1674324
- Filed
- Nov 12, 2021
- Reporting period
- Nov 02, 2021
- Description
- Schedule 13D beneficial ownership